Kynam Capital Management, LP Nektar Therapeutics Transaction History
Kynam Capital Management, LP
- $1.22 Billion
- Q3 2024
A detailed history of Kynam Capital Management, LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Kynam Capital Management, LP holds 200,000 shares of NKTR stock, worth $136,000. This represents 0.08% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$136,000% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NKTR
# of Institutions
145Shares Held
139MCall Options Held
32.6KPut Options Held
14.1K-
Deep Track Capital, LP Greenwich, CT15.9MShares$10.8 Million0.76% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$10.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$8.92 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA9.4MShares$6.39 Million0.22% of portfolio
-
Samlyn Capital, LLC New York, NY9.2MShares$6.26 Million0.19% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $127M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...